glp 1 and papillary thyroid cancer Do GLP-1 Agonists Cause (Wegovy, Saxenda, Etc.) GLP-1RA initiation linked to new

Lancet 356:469474 Sokol RJ, Twedt D, McKim JM Jr., Devereaux MW, Karrer FM, Kam I et al (1994) Oxidant injury to hepatic mitochondria in patients with Wilsons disease and Bedlington terriers with copper toxicosis

Under the therapeutic concentrations, approximately 60%90% of APAP is metabolized in the liver by glucuronidation and sulfation, with a small part (approximately 5%15%) being metabolized by the cytochrome P450 pathway (CYP450) ( via two pathways to form the toxic intermediate N-acetyl-p-benzoquinone imine (NAPQI) and the non-toxic catechol metabolite 3-hydroxy-APAP (3-OH-APAP) (Figure 1)

10.1038/nrneph.2012.112 Nat Rev Nephrol

This bioactive complex naturally occurs in human plasma and tissues